We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STRA:NASDAQStrategic Education, Inc. Analysis

Data as of 2026-08-31 - not real-time

$84.64

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

At $84.64, Strategic Education, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Over a rolling month the price has gained 10.6%. With RSI at 56.2 the momentum picture is neutral, alongside a bullish MACD signal. Price has been bracketed by support at $77.81 and resistance at $86.76.
On valuation the read is fair — an earnings multiple of 14.1, absent a reliable peer benchmark. Consensus targets land 16.2% above where the shares trade now. Revenue is growing at 4.9% on a 10.5% profit margin. The 2.84% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 38.1%, a beta of 0.10 and a maximum drawdown of 16.4%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 5/10 conviction.

Top Market Events

Morningstar%2c Inc.18dStrategic Education, Inc. and Leading Education Investors Seek Edtech Innovators for Second...Detailed price information for Strategic Education STRA-Q from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 80.42
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 80.42
  • Analyst targets imply +16.2% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Analyst targets imply +16.2% versus the current price
  • P/E ratio of 14.1
  • Dividend yield of 2.84%

Key Metrics & Analysis

Financial Health

Revenue Growth4.90%
Profit Margin10.46%
P/E Ratio14.1
ROE8.15%
ROA6.07%
Debt/Equity6.53
P/B Ratio1.1
Op. Cash Flow$215.9M
Free Cash Flow$154.8M

Technical Analysis

TrendBullish
RSI56.2
Support$77.81
Resistance$86.76
MA 20$83.05
MA 50$80.86
MA 200$80.42
MACDBullish
VolumeDecreasing
Fear & Greed Index93.93

Valuation

Fair Value$111.37
Target Price$98.33
Upside/Downside16.18%
GradeFair
TypeValue
Dividend Yield2.84%

Risk Assessment

Beta0.10
Volatility38.12%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.